Ned Jensen

Ned L. Jensen was born in 1948 in Pocatello, Idaho. He has been married to his wife Kathleen for 36 years and they are the parents of six children. Mr. Jensen graduated with high honors from Davis High School in Kaysville, Utah in 1966. He then attended Brigham Young University and the University of Utah, receiving a bachelor's degree in chemistry from the latter in 1971.

Following his university training Mr. Jensen accepted a position with Albion Laboratories in Clearfield, Utah. There he developed new methods for analyzing amino acids in hair, blood and urine. In 1973, while completing his Masters degree at the University of Utah, Mr. Jensen was made Director of Research and Development at Albion. In this capacity he developed new methods of chelating minerals with amino acids and vitamins.

In addition, he performed studies using radioactive isotopes in animals. From these studies came the research that resulted in two US patents. One on the method of chelating minerals into glandular supplements; and the other using buffering agents to stabilize chelated minerals in solution and in dry form. He also directed a human study in which chelated minerals were administered to human subjects. Mr. Jensen monitored the changes in mineral levels in the hair, blood, saliva and urine, as well as general physiology.

In 1976, Mr. Jensen relocated to Concord, California to become the Director of the Laboratory and of Research and Development at Seroyal Brands, Inc. There he designed and built a new laboratory and was granted a clinical license to run the facility. While at Seroyal Mr. Jensen formulated all of the supplements and drugs produced by the company. These included time released vitamins, ointments, salves, homeopathics, New Zealand glandular products, amino acid chelated minerals, and herbal extracts and tablets. Mr. Jensen also established the clinical laboratory, Seroyal Analytical Lab, which performed mineral analysis on blood, hair and urine to determine heavy metal toxicities and trace mineral deficiencies. He wrote software that correlated data and produced reports making dietary and supplement recommendations to correct mineral deficiencies and imbalances. He also wrote a computer diet analysis program which correlates 51 nutrients tabulated from a weekly questionnaire and results in a report specifying the RDA of applicable nutrients, and which supplements are necessary to correct deficiencies.

Perhaps most notably, Mr. Jensen is responsible for developing the niacin based GTF (Glucose Tolerance Factor) Chromium Complex. Several animal and human studies have verified his work. One study was done at the Linus Pauling Research Institute which also validated the efficacy of the complex. More recent studies have been conducted at Auburn University and the University of California at Davis. He currently holds 5 United States patents on the use, method, and preparation of the GTF Chromium Complex also known and sold as Chromate. These studies show that his patented complex is 3 times better absorbed than chromium picolinate and 6 times better absorbed than chromium chloride.

Recent inventions attributable to Mr. Jensen include stabilized colloidal silver and gold preparations and a new chromium complex which is 10 times more effective than his patented Chromate GTF Complex. Tests have shown that his silver colloid is stable for more than three years with only a 1% degradation. Most other silver complexes degrade at the rate of 5-10% per month. He has also developed a new lipid micelle method for incorporating fat soluble vitamins in aqueous solutions. He has developed new analytical methods to measure the amylase blocking effects of phaseolamine extracts. Recent clinical studies have shown these extracts are useful in slowing the breakdown of starch in the diet to sugar, thus curbing the peaks and valleys found in glucose levels associated with high carbohydrate diets.

Currently, Mr. Jensen is President of MBi Nutraceuticals. Mr. Jensen's companies manufacture supplements and homeopathic drugs in many forms including tablets, capsules, liquids, powders and gels. The facilities are certified cGMP (Good Manufacturing Practices) and hold proper manufacturing licenses. The facilities manufacture MBi products as well as for many other companies in the United States and around the world.